U.S. Military HIV Research Program
Zoltan Beck has not added Biography.
If you are Zoltan Beck and would like to personalize this page please email our Author Liaison for assistance.
HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies.
Molecular membrane biology Nov-Dec, 2006 | Pubmed ID: 17127618
Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites.
Journal of virology Feb, 2007 | Pubmed ID: 17151131
Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes.
Biochemical and biophysical research communications Feb, 2008 | Pubmed ID: 18088597
Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1.
Biochimica et biophysica acta Mar, 2009 | Pubmed ID: 19100711
Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
AIDS (London, England) Oct, 2009 | Pubmed ID: 19710597
Human erythrocytes selectively bind and enrich infectious HIV-1 virions.
PloS one Dec, 2009 | Pubmed ID: 20011536
Infection of human peripheral blood mononuclear cells by erythrocyte-bound HIV-1: effects of antibodies and complement.
Virology Apr, 2011 | Pubmed ID: 21334707
Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.
Vaccine Jun, 2013 | Pubmed ID: 23624097
Platelets and erythrocyte-bound platelets bind infectious HIV-1 in plasma of chronically infected patients.
PloS one , 2013 | Pubmed ID: 24282562
Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine.
Vaccine Mar, 2014 | Pubmed ID: 24486371
Synthesis and immunological effects of heroin vaccines.
Organic & biomolecular chemistry Oct, 2014 | Pubmed ID: 24995943
Adjuvants for vaccines to drugs of abuse and addiction.
Vaccine Sep, 2014 | Pubmed ID: 25111169
Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate.
Biochimica et biophysica acta Mar, 2015 | Pubmed ID: 25511587
Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.
Bioconjugate chemistry Jun, 2015 | Pubmed ID: 25970207
Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21.
Vaccine Oct, 2015 | Pubmed ID: 26372857
Liposomal adjuvants for human vaccines.
Expert opinion on drug delivery Jun, 2016 | Pubmed ID: 26866300
Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants.
Vaccine 10, 2017 | Pubmed ID: 28274638
Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013.
Vaccine 07, 2017 | Pubmed ID: 28596090
A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse.
Journal of medicinal chemistry 01, 2018 | Pubmed ID: 29236495
Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant.
NPJ vaccines , 2017 | Pubmed ID: 29263870
Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.
Journal of controlled release : official journal of the Controlled Release Society 04, 2018 | Pubmed ID: 29432824
Self-Assembling Protein Nanoparticles: implications for HIV-1 vaccine development.
Nanomedicine (London, England) 09, 2018 | Pubmed ID: 30270731
Saturated phospholipids are required for nano- to micron-size transformation of cholesterol-containing liposomes upon QS21 addition.
Journal of liposome research Sep, 2019 | Pubmed ID: 30350748
Design and characterization of a self-assembling protein nanoparticle displaying HIV-1 Env V1V2 loop in a native-like trimeric conformation as vaccine antigen.
Nanomedicine : nanotechnology, biology, and medicine 02, 2019 | Pubmed ID: 30576800
Glycosylation of the HIV-1 Env V1V2 loop to form a native-like structure may not be essential with a nanoparticle vaccine.
Future virology Feb, 2019 | Pubmed ID: 30815025
Enhanced Immunogenicity and Protective Efficacy of a Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21.
mSphere 05, 2019 | Pubmed ID: 31043512
Correction for Ramakrishnan et al., "Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21".
mSphere May, 2019 | Pubmed ID: 31118306
Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ).
Vaccine Jun, 2019 | Pubmed ID: 31151801
Particle size analyses of polydisperse liposome formulations with a novel multispectral advanced nanoparticle tracking technology.
International journal of pharmaceutics Jul, 2019 | Pubmed ID: 31176851
Erratum for Ramakrishnan et al., "Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21".
mSphere Jun, 2019 | Pubmed ID: 31243083
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved